CSL secured rights to MSD's vaccines in Australia and New Zealand as part of an agreement negotiated in the 1990s under which the US company gained global development and commercialisation rights to the investigative candidate that became GARDASIL.
MSD to bring vaccine distribution back in-house after 40-year partnership
December 1, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
GBMA White Paper calls for reforms to strengthen supply chain resilience
August 10, 2026 - - Latest News -
France the first to provide comprehensive reimbursement for GLP-1s for weight loss while Australia looks on
August 10, 2026 - -
New Zealand's ACT announces plan for pharmacies to do a lot more, but also ownership and location reform
August 10, 2026 - -
Achieving value is meaningless if it undermines access to medicines
August 10, 2026 - -
Australia’s 'Biggest Week in Biotech' brings global life sciences leaders to the Gold Coast
August 9, 2026 - - Australian Biotech -
The 'Dispatched' Podcast - Week in review
August 7, 2026 - - Podcast -
A new generation is rewriting their lives living with Cystic Fibrosis
August 7, 2026 - - Latest News

